Bronchiolitis Obliterans Syndrome (BOS) Terminated Phase 1 / 2 Trials for Itacitinib (DB12154)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03978637Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung TransplantationTreatment